(Q45847458)

English

Modification of tumor cells by a low dose of Newcastle disease virus. II. Augmented tumor-specific T cell response as a result of CD4+ and CD8+ immune T cell cooperation

scientific article published in January 1989

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/2462467

Modification of tumor cells by a low dose of Newcastle disease virus. II. Augmented tumor-specific T cell response as a result of CD4+ and CD8+ immune T cell cooperation (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/2462467

1 reference

based on heuristic

inferred from title

Newcastle disease

1 reference

based on heuristic

inferred from title

Newcastle disease virus

object named as

Newcastle disease virus

1 reference

based on heuristic

inferred from title

author name string

H Schild

1

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/2462467

P von Hoegen

2

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/2462467

V Schirrmacher

3

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/2462467

publication date

1 January 1989

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/2462467

Cancer Immunology, Immunotherapy

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/2462467

28

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/2462467

1

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/2462467

22-28

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/2462467

The biological modification of tumor cells as a means of inducing their regression: an overview

1 reference

https://pubmed.ncbi.nlm.nih.gov/2462467

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

T cell growth factor: parameters of production and a quantitative microassay for activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/2462467

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A rapid colorimetric assay for the determination of IL-2-producing helper T cell frequencies

1 reference

https://pubmed.ncbi.nlm.nih.gov/2462467

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of metastatic spread by postoperative immunotherapy with virally modified autologous tumor cells. III. Postoperative activation of tumor-specific CTLP from mice with metastases requires stimulation with the specific antigen plus additiona

1 reference

https://pubmed.ncbi.nlm.nih.gov/2462467

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD4+ helper T cells are required for resistance to a highly metastatic murine tumor.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2462467

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin 2 is not sufficient as helper component for the activation of cytotoxic T lymphocytes but synergizes with a late helper effect that is provided by irradiated I-region-incompatible stimulator cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2462467

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Viral Xenogenization of Intact Tumor Cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2462467

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New antigens presented on tumor cells can cause immune rejection without influencing the frequency of tumor-specific cytolytic T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2462467

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement

1 reference

https://pubmed.ncbi.nlm.nih.gov/2462467

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alloantigen-activated lymphocytes from mice bearing a spontaneous "nonimmunogenic" adenocarcinoma inhibit its growth in vivo by recruiting host immunoreactivity.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2462467

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Virus Augmentation of The Antigenicity of Tumor Cell

1 reference

https://pubmed.ncbi.nlm.nih.gov/2462467

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of metastatic spread by postoperative immunotherapy with virally modified autologous tumor cells. I. Parameters for optimal therapeutic effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/2462467

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

T-T cell interaction in the induction of delayed-type hypersensitivity (DTH) responses: vaccinia virus-reactive helper T cell activity involved in enhanced in vivo induction of DTH responses and its application to augmentation of tumor-specific DTH

1 reference

https://pubmed.ncbi.nlm.nih.gov/2462467

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Strategies for cell-mediated immunotherapy of cancer: killing or help?

1 reference

https://pubmed.ncbi.nlm.nih.gov/2462467

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Helper T cells against tumor-associated antigens (TAA): preferential induction of helper T cell activities involved in anti-TAA cytotoxic T lymphocyte and antibody responses

1 reference

https://pubmed.ncbi.nlm.nih.gov/2462467

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/2462467

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of interleukin-2 receptors as a differentiation marker on intrathymic stem cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2462467

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Resistance of metastatic tumor variants to tumor-specific cytotoxic T-lymphocytes not due to defects in expression of restricting major histocompatibility complex molecules in murine cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2462467

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1 reference

https://pubmed.ncbi.nlm.nih.gov/2462467

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Newcastle disease virus: the effect of monoclonal antibody in the overlay on virus penetration and the immunoselection of variants

1 reference

https://pubmed.ncbi.nlm.nih.gov/2462467

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. VI. Similar specificity patterns of protective anti-tumor immunityin vivo and of cytolytic T cellsin vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/2462467

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of metastatic spread by postoperative immunotherapy with virally modified autologous tumor cells. II. Establishment of specific systemic anti-tumor immunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/2462467

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule

1 reference

https://pubmed.ncbi.nlm.nih.gov/2462467

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modification of tumor cells by a low dose of Newcastle disease virus. Augmentation of the tumor-specific T cell response in the absence of an anti-viral response

1 reference

https://pubmed.ncbi.nlm.nih.gov/2462467

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The augmentation of tumor-specific immunity by virus help. III. Enhanced generation of tumor-specific Lyt-1+2- T cells is responsible for augmented tumor immunity in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/2462467

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00205796

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/2462467

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/2462467

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45847458&oldid=2207380320"